About: Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Arguments in favour of remdesivir for treating SARS-CoV-2 infections Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 06 March 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en marzu de 2020 (ast) scientific article published on 06 March 2020 (en) наукова стаття, опублікована 6 березня 2020 (uk)
publication date	wds:Q90138891-1F51A865-A9D0-4763-BBBE-7E7F9BAAF2AB
publication date	2020-03-06 00:00:00Z (xsd:dateTime)
cites work	wds:Q90138891-0949809E-2AEA-44D6-AB97-E5647446B601 wds:Q90138891-0A0F6567-28B9-49C2-B482-6CD7A8B59C37 wds:Q90138891-0B7CAFC4-3BFB-4A89-A94C-94D2FF74B607 wds:Q90138891-204CE220-90BD-4387-A66E-8CA187129460 wds:Q90138891-2216C3E8-C7D6-4B31-8922-343E4070B672 wds:Q90138891-2DC217C1-FE23-4EC8-B6AC-CB29DE09EF61 wds:Q90138891-363E71A7-FC9F-4653-8DCB-1CB8731A998A wds:Q90138891-4BF0E438-0148-4DBC-86C4-F03A316B1513 wds:Q90138891-5316C359-C8D4-4B54-9CC0-C2F55CE1597E wds:Q90138891-56863BD7-4C88-4C76-A8DA-6FDD8610B772 wds:Q90138891-61D3E29E-E590-42C8-ABA4-B1BE70AC6FE1 wds:Q90138891-81781808-C8D6-40B9-AF4C-061043FA6CD6 wds:Q90138891-94FB3651-660A-4DBF-93E3-410D4F807F6E wds:Q90138891-9C0DA488-20D9-4B11-AC35-E140EFD686D3 wds:Q90138891-A42FE171-8A71-40DE-9574-F2D6738077A6 wds:Q90138891-AF24B00C-71D1-4D58-8CA2-F66E447E6E1F wds:Q90138891-B0BBB395-DB21-412F-9D74-C1DE5E0A7177 wds:Q90138891-B9A17664-31DD-41AA-839C-63C08B745C56 wds:Q90138891-D03E415D-F589-473A-8527-7C82E69706A8 wds:Q90138891-D24D91E3-87B7-4F86-90C9-E35CC9A0841F wds:Q90138891-DC9BCB0E-E53E-49F1-B6C6-F00A6BEBA24C wds:Q90138891-F12EC701-695C-4D6C-A4C1-03CDF128D24D wds:Q90138891-F166A999-B0D8-40A8-AA8D-CE2C00798B48
cites work	Late Ebola virus relapse causing meningoencephalitis: a case report GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Coronaviruses: genome structure, replication, and pathogenesis Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia A Novel Coronavirus from Patients with Pneumonia in China, 2019 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics First Case of 2019 Novel Coronavirus in the United States Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase Chloroquine for the 2019 novel coronavirus SARS-CoV-2
author name string	wds:Q90138891-149A3447-5803-4F7D-B046-8B57A5E81A60 wds:Q90138891-164C0A77-2C7A-482C-A61E-3A740926FC0C wds:Q90138891-4083F7B5-2059-41AC-A366-7640B9D3195F wds:Q90138891-40AE0FC8-FB07-4946-BD8C-0BFA410820AD wds:Q90138891-67337EDA-E7B3-439D-8E5A-F97DFE1C01BA wds:Q90138891-D4CBBB05-C380-4C1F-A3BE-AEEC9E905595
author name string	Jean-Marc Rolain Ping-Ing Lee Wen-Chien Ko Nan-Yao Lee Po-Lin Chen Ching-Tai Huang
rdfs:label	Arguments in favour of remdesivir for treating SARS-CoV-2 infections (en) Arguments in favour of remdesivir for treating SARS-CoV-2 infections (nl)
skos:prefLabel	Arguments in favour of remdesivir for treating SARS-CoV-2 infections (en) Arguments in favour of remdesivir for treating SARS-CoV-2 infections (nl)
name	Arguments in favour of remdesivir for treating SARS-CoV-2 infections (en) Arguments in favour of remdesivir for treating SARS-CoV-2 infections (nl)
author	wds:Q90138891-6941CEDF-1EAB-4B35-9ABC-D91BEE377347
author	Po-Ren Hsueh
title	wds:Q90138891-AE550F06-1F6C-4276-9B72-D2368EAC4095
title	Arguments in favour of remdesivir for treating SARS-CoV-2 infections (en)
page(s)	wds:Q90138891-BAA73151-8F3D-4E20-B0F0-8AA67428471D
page(s)	105933
instance of	wds:Q90138891-12F3F4C3-0F02-44A0-B706-1BA08B51670F wds:Q90138891-61caa670-3a6f-4b80-9f85-aa130ebe7dda
instance of	editorial scholarly article
main subject	wds:Q90138891-7C489C8A-D4C8-4298-A7CB-33D6FE2649E0 wds:Q90138891-A68EC6C3-9FD8-41ED-9790-3B9DC4C0D57D wds:Q90138891-FD2A7C6A-EA1E-4B90-8EB6-D178288AB7BD
main subject	SARS-CoV-2 COVID-19 mortality remdesivir
PubMed ID	wds:Q90138891-733330E4-2D5F-4706-9537-AD5A1EB71986
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32147516
PubMed ID	32147516
published in	wds:Q90138891-390B0E5E-8C9B-4257-8967-18C592982B25
published in	International Journal of Antimicrobial Agents
issue	wds:Q90138891-8BE5AA92-0295-49B5-A690-8427F7EA4116
volume	wds:Q90138891-842C522A-C3DE-48C6-97E5-1AD9B5840086
issue	4
volume	55
DOI	wds:Q90138891-38B8E559-0D72-4249-88AF-AA18619EE92B
DOI	http://dx.doi.org/10.1016/J.IJANTIMICAG.2020.105933
DOI	10.1016/J.IJANTIMICAG.2020.105933
Semantic Scholar corpus ID	wds:Q90138891-5ED8E531-13D6-407E-9D6E-1DC036DF5360

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software